Bioscrip, Inc. - Statement of Changes in Beneficial Ownership (4)
13 Février 2008 - 11:09PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Expires:
January 31, 2008
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
FRIEDMAN RICHARD H
|
2. Issuer Name
and
Ticker or Trading Symbol
BioScrip, Inc.
[
BIOS
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
Chairman of the Board and CEO
|
(Last)
(First)
(Middle)
100 CLEARBROOK ROAD
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
2/12/2008
|
(Street)
ELMSFORD, NY 10523
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock, $.0001 par value
|
|
|
|
|
|
|
|
935668.00
|
D
|
|
Common Stock, $.0001 par value
|
|
|
|
|
|
|
|
20000.00
|
I
|
By Shares Held By Ltd Partnership
(1)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Employee Stock Option (Right to Buy)
|
$7.70
|
2/12/2008
|
|
A
|
|
70000.00
(2)
|
|
1/2/2009
|
1/2/2018
|
Common Stock, $.0001 par value
|
70000.00
|
$0.00
|
70000.00
|
D
|
|
Employee Stock Option
|
$3.46
|
|
|
|
|
|
|
1/2/2008
(3)
|
1/2/2017
|
Common Stock, $.0001 par value
|
200000.00
|
|
200000.00
|
D
|
|
Employee Stock Option (Right to Buy Common Stock)
|
$2.16
|
|
|
|
|
|
|
10/8/2000
(4)
|
10/8/2009
|
Common Stock, $.0001 par value
|
207806.00
|
|
207806.00
|
D
|
|
Employee Stock Option (Right to Buy Common Stock)
|
$2.37
|
|
|
|
|
|
|
10/8/2000
(4)
|
10/8/2009
|
Common Stock, $.0001 par value
|
42194.00
|
|
42194.00
|
D
|
|
Employee Stock Option (Right to Buy Common Stock)
|
$12.20
|
|
|
|
|
|
|
11/28/2002
(4)
|
11/20/2011
|
Common Stock, $.0001 par value
|
200000.00
|
|
200000.00
|
D
|
|
Employee Stock Option (Right to Buy Common Stock)
|
$17.80
|
|
|
|
|
|
|
1/2/2003
(4)
|
1/2/2012
|
Common Stock, $.0001 par value
|
200000.00
|
|
200000.00
|
D
|
|
Employee Stock Option (Right to Buy Common Stock)
|
$5.80
|
|
|
|
|
|
|
1/2/2004
(4)
|
1/2/2013
|
Common Stock, $.0001 par value
|
200000.00
|
|
200000.00
|
D
|
|
Employee Stock Option (Right to Buy Common Stock)
|
$7.54
|
|
|
|
|
|
|
1/3/2007
(3)
|
1/3/2016
|
Common Stock, $.0001 par value
|
200000.00
|
|
200000.00
|
D
|
|
Employee Stock Option (Right to Buy Common Stock)
|
$7.03
|
|
|
|
|
|
|
1/2/2005
(4)
|
1/2/2014
|
Common Stock, $.0001 par value
|
200000.00
|
|
200000.00
|
D
|
|
Employee Stock Option (Right to Buy)
|
$6.36
|
|
|
|
|
|
|
1/3/2006
(4)
|
1/3/2015
|
Common Stock, $.0001 par value
|
200000.00
|
|
200000.00
|
D
|
|
Employee Stock Option (Right to Buy)
|
$7.70
|
|
|
|
|
|
|
1/2/2009
|
1/2/2018
|
Common Stock, $.0001 par value
|
130000.00
|
|
130000.00
(2)
|
D
|
|
Explanation of Responses:
|
(
1)
|
Shares of Common Stock are owned by the Richard Friedman Family Limited Partnership, of which Mr. Friedman is a general and limited partner. Mr. Friedman has shared voting and dispositive power with respect to these shares of Common Stock.
|
(
2)
|
Pursuant to the terms of the Restated Employment Agreement, dated November 29, 2006, between the reporting person and the issuer, the reporting person is entitled to receive a grant of options to purchase 200,000 shares of the issuer's common stock on the first business day of each year. On January 2, 2008 there was an insufficient number of shares remaining available for grant under the issuer's stock option plan to issue the full number of options that the reporting person was entitled to receive on such date. As a result of such shortfall the reporting person was issued options to purchase 130,000 shares. Due to certain option cancellations after January 2, 2008 additional shares became available for grant under the stock option plan and the balance of the 70,000 was issued to the reporting person on February 12, 2008.
|
(
3)
|
Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
|
(
4)
|
Fully Vested
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
FRIEDMAN RICHARD H
100 CLEARBROOK ROAD
ELMSFORD, NY 10523
|
X
|
|
Chairman of the Board and CEO
|
|
Signatures
|
/s/ Richard H. Friedman
|
|
2/13/2007
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024
Real-Time news about BioPlus Acquisition Corporation (NASDAQ): 0 recent articles
Plus d'articles sur Bioscrip, Inc.